Mule Edward A's Form 4 filing
Keenova Therapeutics plc (MNKTQ) · filed Dec 10, 2025
- Accession no.
- 0001193125-25-314511
- Filed
- Dec 10, 2025, 6:14 PM ET
- Trade date
- Dec 8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $11.6M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mule Edward ACIK 0001029625 | 10% Owner |
| Silver Point Capital L.P.CIK 0001332784 | 10% Owner |
| O'Shea Robert JCIK 0001382617 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Common Stock | PPurchaseAcquired | +130,974 | $88.75 | +$11,623,942.5 | 4,702,714 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.